1. Home
  2. MSBI vs CERS Comparison

MSBI vs CERS Comparison

Compare MSBI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

HOLD

Current Price

$30.54

Market Cap

603.7M

Sector

Finance

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$3.13

Market Cap

585.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSBI
CERS
Founded
1881
1991
Country
United States
United States
Employees
861
N/A
Industry
Major Banks
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
603.7M
585.1M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MSBI
CERS
Price
$30.54
$3.13
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$24.33
N/A
AVG Volume (30 Days)
184.8K
3.1M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
5.00%
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
$18.41
$19.95
Revenue Next Year
$2.07
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$14.24
$1.15
52 Week High
$31.68
$3.47

Technical Indicators

Market Signals
Indicator
MSBI
CERS
Relative Strength Index (RSI) 59.59 62.77
Support Level $27.07 $2.37
Resistance Level $31.68 $3.14
Average True Range (ATR) 0.86 0.18
MACD -0.16 0.03
Stochastic Oscillator 56.48 63.70

Price Performance

Historical Comparison
MSBI
CERS

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Share on Social Networks: